Article thumbnail

Predictors of Impaired Glucose Regulation in Patients with Non-Alcoholic Fatty Liver Disease

By Erifili Hatziagelaki, Drosos E. Karageorgopoulos, Athina Chounta, Anastasia Tsiavou, Matthew E. Falagas and George Dimitriadis


Introduction. Many patients with non-alcoholic fatty liver disease (NAFLD) have impaired glucose regulation or type 2 diabetes mellitus (DM). We investigated characteristics of NAFLD patients associated with hyperglycemia. Methods. During a 2-hour oral glucose tolerance test (OGTT), serum glucose and insulin were measured in 152 NAFLD patients. Results. 48.7% of NAFLD patients had hyperglycemia. Age (odds ratio (OR) = 1.08, 95% confidence interval (CI): 1.03–1.13), body mass index (BMI) (OR = 1.12, 95% CI: 1.01–1.25), and lower high-density lipoprotein cholesterol (HDL-C) (OR = 0.95, 95% CI: 0.92–0.98) proved to be independent predictors of hyperglycemia. After OGTT, 30 min insulin was lower in hyperglycemic patients (74.2 ± 49.7 versus 94.5 ± 53.9 μIU/mL, P = 0.02), while 90 min insulin (170.1 ± 84.6 versus 122.9 ± 97.7 μU/mL, P = 0.01) and 120 min insulin (164.0 ± 101.2 versus 85.3 ± 61.9 μIU/mL, P < 0.01) were higher. Conclusions. NAFLD patients with higher BMI, lower HDL-C, or older age were more likely to have impaired glucose metabolism. An OGTT could be of value for early diagnosis of DM among this population

Topics: Research Article
Publisher: Hindawi Publishing Corporation
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (2005). A d a m s ,J .F .L ym p ,J .S .S a u v e re ta l . ,“T h en a t u r a lh i s t o ry of nonalcoholic fatty liver disease: a population-based cohort study,”
  2. (2009). Abnormal glucose tolerance in young male patients with nonalcoholic fatty liver disease,”
  3. (2005). Abnormal glucose tolerance is a predictor of steatohepatitis and fibrosis in patients with non-alcoholic fatty liver disease,”
  4. (2002). AGA technical review on nonalcoholic fatty liver disease,”
  5. (1995). C h e n ,E .J .B o y k o ,R .W .B e r g s t r o me ta l . ,“ E a r l i e r appearance of impaired insulin secretion than of visceral adiposity in the pathogenesis of NIDDM: 5-year follow-up of initially nondiabetic Japanese-American men,” Diabetes Care,
  6. (1990). Cardiovascular risk factors in confirmed prediabetic individuals,”
  7. (2008). Causes and metabolic consequences of fatty liver,”
  8. (2004). Diagnostic and therapeutic implications of relationships between fasting, 2-hour postchallenge plasma glucose and hemoglobin A1c values,”
  9. (2006). Effect of pioglitazone on pancreatic β-cell function and diabetes riskExperimental
  10. (2010). Environmental and genetic determinants of fatty liver
  11. (2008). Fatty liver is independently associated with alterations in circulating HDL2 andHDL3subfractions,”DiabetesCare,vol.31,no.2,pp.366– 368,
  12. (2003). Follow-up report on the diagnosis of diabetes mellitus,”
  13. (1998). Hyperlipidemia and diabetes mellitus,”
  14. (2005). Insulin resistance, the metabolic syndrome, and nonalcoholic fatty liver disease,”
  15. (2004). Isik et al., “Metformin in the treatment of patients with non-alcoholic steatohepatitis,”
  16. (1980). J.H.Fuller,M.J.Shipley,andG.Rose,“Coronaryheartdisease risk and impaired glucose tolerance.
  17. (1998). L e v y ,D .R .M a t t h e w s ,a n dM .P .H e r m a n s ,“ C o r r e c t homeostasis model assessment (HOMA) evaluation uses the computer program,”
  18. (2009). Long-term follow-up of patients with nonalcoholic fatty liver,”
  19. (2004). Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease,”
  20. (2004). Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults,”
  21. (1999). Morselli-Labate et al., “Association of nonalcoholic fatty liver disease with insulin resistance,”
  22. (2007). N a t h a n ,M .B .D a v i d s o n ,R .A .D e F r o n z oe ta l . , “Impaired fasting glucose and impaired glucose tolerance: implications for care,” Diabetes Care,
  23. (2007). Nathan,andR.B.D’Agostino,“Predictionofincidentdiabetes mellitus in middle-aged adults: the Framingham Offspring
  24. (2008). Nonalcoholic fatty liver disease is associated with hepatic and skeletal muscle insulin resistance in overweight adolescents,”
  25. (2001). Nonalcoholic fatty liver disease: a feature of the metabolic syndrome,”
  26. (2001). Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities,”
  27. (2007). P.Angulo,J.M.Hui,G.Marchesinietal.,“TheNAFLDfibrosis score: a noninvasive system that identifies liver fibrosis in patients with
  28. (2005). Prevalence of and risk factors for nonalcoholicfattyliverdisease:thedionysosnutritionandliverstudy,”
  29. (2010). Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis,”
  30. (2008). Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis,”
  31. (2000). Ratio of triglycerides to HDL cholesterol is an indicator of LDL particle size
  32. (2000). Sullivan,E.H.M orrato ,V .Ghushch yan,H.R.W yatt,and
  33. (2010). The impact of liver fat vs visceral fat in determining categories of prediabetes,”
  34. (1990). The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years,”
  35. (2006). Tsang et al., “Prevalence of undiagnosed diabetes and postchallenge hyperglycaemia in Chinese patients with non-alcoholic fatty liver disease,” Alimentary Pharmacology and Therapeutics,v o l .2 4 ,n o .8 ,p p .
  36. (2003). Use of metabolic markers to identify overweight individuals who are insulin resistant,” Annals of internal medicine,
  37. (1998). Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes?